2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Strontium-89: new trials by email Literature Review of Strontium-89 trials Research Report on Strontium-89
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases Doxorubicin hydrochloride, Goserelin acetate, Leuprolide acetate - Metastatic Cancer, Prostate Cancer | Phase 2 | Completed | M.D. Anderson Cancer Center | 80 | 2004-07-01 | 2016-11-10 |
| A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer strontium-89, cisplatin - Hormone Refractory Prostate Cancer, Bone Metastases | Phase 2 | Completed | Alberta Health services | 58 | 2003-08-01 | 2012-01-19 |
| Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases Celecoxib, Doxorubicin Hydrochloride, Strontium chloride Sr 89 - Metastatic Cancer, Prostate Cancer | Phase 2 | Terminated | M.D. Anderson Cancer Center | 14 | 2002-02-01 | 2018-10-31 |
Prostatic Neoplasms (3) · Neoplasm Metastasis (2)
M.D. Anderson Cancer Center (2) · Alberta Health services (1)
United States (2) · Canada (1)
Shi-Ming Tu, MD (2) · Bernie Eigl, MD (1) · Jackson Wu (1)
P30CA016672 (1), P50CA090270 (1), U10CA045809 (1)